Key facts
- It has raised $5.2M; the latest was Seed Round ($550K) in Feb 2026.
- Notable investors include Ontario Centre of Innovation, Sunnybrook Research Institute, Toronto Innovation Acceleration Partners.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Northern Vascular Systems
- ·The full record, as it builds
Funding rounds
No funding rounds for Northern Vascular Systems are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Northern Vascular Systems
Developer of a light-activated liquid embolic platform designed to enable on-demand solidification of embolic materials for controlled vascular occlusion. The company's technology consists of a photo-curable embolic agent, a delivery catheter with embedded optical fiber, and an accompanying laser module, empowering clinicians and contributing to the future of safe and effective embolic treatment.
- Sector
- Healthcare
- HQ
- Toronto, Canada
- Founded
- 2021
- Employees
- 10
- Website
- northvasc.com/
- Ownership
- Privately Held (backing)
Northern Vascular Systems doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Northern Vascular Systems shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Northern Vascular Systems in its N-PORT filings yet. We sweep new filings monthly.